SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 89 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2021$39,000
-59.8%
38,302
-27.8%
0.00%
-50.0%
Q2 2021$97,000
-76.2%
53,033
-74.3%
0.00%
-71.4%
Q1 2021$407,000206,6130.01%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders